The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Venous Thromboembolism Therapy Market Research Report 2025

Global Venous Thromboembolism Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1675703

No of Pages : 94

Ask Your Query
Synopsis
A venous thrombus is a blood clot (thrombus) that forms within a vein. Thrombosis is a term for a blood clot occurring inside a blood vessel. A common type of venous thrombosis is a deep vein thrombosis (DVT), which is a blood clot in the deep veins of the leg. If the thrombus breaks off (embolizes) and flows towards the lungs, it can become a pulmonary embolism (PE), a blood clot in the lungs.
The global Venous Thromboembolism Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Therapy.
Report Scope
The Venous Thromboembolism Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Venous Thromboembolism Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Stryker
AngioDynamics
Cook Medical
Cardinal Health
DJO Global
Philips Holding
ArjoHuntleigh AB
Argon Medical Devices
DaeSung Maref
ALN Implants Chirurgicaux
Lifetech Scientific
Segment by Type
Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Venous Thromboembolism Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Venous Thromboembolism Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Venous Thromboembolism Therapy Market Overview
1.1 Product Overview and Scope of Venous Thromboembolism Therapy
1.2 Venous Thromboembolism Therapy Segment by Type
1.2.1 Global Venous Thromboembolism Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Non-Segmented Pneumatic Compression Pumps
1.2.3 Segmented Pneumatic Compression Pumps without Gradient
1.3 Venous Thromboembolism Therapy Segment by Application
1.3.1 Global Venous Thromboembolism Therapy Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Venous Thromboembolism Therapy Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Therapy Revenue 2019-2030
1.4.2 Global Venous Thromboembolism Therapy Sales 2019-2030
1.4.3 Global Venous Thromboembolism Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Venous Thromboembolism Therapy Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Venous Thromboembolism Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Venous Thromboembolism Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Venous Thromboembolism Therapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Venous Thromboembolism Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venous Thromboembolism Therapy, Product Type & Application
2.7 Venous Thromboembolism Therapy Market Competitive Situation and Trends
2.7.1 Venous Thromboembolism Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism Therapy Players Market Share by Revenue
2.7.3 Global Venous Thromboembolism Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Venous Thromboembolism Therapy Retrospective Market Scenario by Region
3.1 Global Venous Thromboembolism Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Venous Thromboembolism Therapy Global Venous Thromboembolism Therapy Sales by Region: 2019-2030
3.2.1 Global Venous Thromboembolism Therapy Sales by Region: 2019-2024
3.2.2 Global Venous Thromboembolism Therapy Sales by Region: 2025-2030
3.3 Global Venous Thromboembolism Therapy Global Venous Thromboembolism Therapy Revenue by Region: 2019-2030
3.3.1 Global Venous Thromboembolism Therapy Revenue by Region: 2019-2024
3.3.2 Global Venous Thromboembolism Therapy Revenue by Region: 2025-2030
3.4 North America Venous Thromboembolism Therapy Market Facts & Figures by Country
3.4.1 North America Venous Thromboembolism Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Venous Thromboembolism Therapy Sales by Country (2019-2030)
3.4.3 North America Venous Thromboembolism Therapy Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Venous Thromboembolism Therapy Market Facts & Figures by Country
3.5.1 Europe Venous Thromboembolism Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Venous Thromboembolism Therapy Sales by Country (2019-2030)
3.5.3 Europe Venous Thromboembolism Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venous Thromboembolism Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Venous Thromboembolism Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Venous Thromboembolism Therapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Venous Thromboembolism Therapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Venous Thromboembolism Therapy Market Facts & Figures by Country
3.7.1 Latin America Venous Thromboembolism Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Venous Thromboembolism Therapy Sales by Country (2019-2030)
3.7.3 Latin America Venous Thromboembolism Therapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venous Thromboembolism Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Venous Thromboembolism Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Venous Thromboembolism Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Venous Thromboembolism Therapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Venous Thromboembolism Therapy Sales by Type (2019-2030)
4.1.1 Global Venous Thromboembolism Therapy Sales by Type (2019-2024)
4.1.2 Global Venous Thromboembolism Therapy Sales by Type (2025-2030)
4.1.3 Global Venous Thromboembolism Therapy Sales Market Share by Type (2019-2030)
4.2 Global Venous Thromboembolism Therapy Revenue by Type (2019-2030)
4.2.1 Global Venous Thromboembolism Therapy Revenue by Type (2019-2024)
4.2.2 Global Venous Thromboembolism Therapy Revenue by Type (2025-2030)
4.2.3 Global Venous Thromboembolism Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Venous Thromboembolism Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Venous Thromboembolism Therapy Sales by Application (2019-2030)
5.1.1 Global Venous Thromboembolism Therapy Sales by Application (2019-2024)
5.1.2 Global Venous Thromboembolism Therapy Sales by Application (2025-2030)
5.1.3 Global Venous Thromboembolism Therapy Sales Market Share by Application (2019-2030)
5.2 Global Venous Thromboembolism Therapy Revenue by Application (2019-2030)
5.2.1 Global Venous Thromboembolism Therapy Revenue by Application (2019-2024)
5.2.2 Global Venous Thromboembolism Therapy Revenue by Application (2025-2030)
5.2.3 Global Venous Thromboembolism Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Venous Thromboembolism Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Venous Thromboembolism Therapy Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Venous Thromboembolism Therapy Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Corporation Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Venous Thromboembolism Therapy Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 AngioDynamics
6.4.1 AngioDynamics Corporation Information
6.4.2 AngioDynamics Description and Business Overview
6.4.3 AngioDynamics Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AngioDynamics Venous Thromboembolism Therapy Product Portfolio
6.4.5 AngioDynamics Recent Developments/Updates
6.5 Cook Medical
6.5.1 Cook Medical Corporation Information
6.5.2 Cook Medical Description and Business Overview
6.5.3 Cook Medical Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cook Medical Venous Thromboembolism Therapy Product Portfolio
6.5.5 Cook Medical Recent Developments/Updates
6.6 Cardinal Health
6.6.1 Cardinal Health Corporation Information
6.6.2 Cardinal Health Description and Business Overview
6.6.3 Cardinal Health Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cardinal Health Venous Thromboembolism Therapy Product Portfolio
6.6.5 Cardinal Health Recent Developments/Updates
6.7 DJO Global
6.6.1 DJO Global Corporation Information
6.6.2 DJO Global Description and Business Overview
6.6.3 DJO Global Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DJO Global Venous Thromboembolism Therapy Product Portfolio
6.7.5 DJO Global Recent Developments/Updates
6.8 Philips Holding
6.8.1 Philips Holding Corporation Information
6.8.2 Philips Holding Description and Business Overview
6.8.3 Philips Holding Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Philips Holding Venous Thromboembolism Therapy Product Portfolio
6.8.5 Philips Holding Recent Developments/Updates
6.9 ArjoHuntleigh AB
6.9.1 ArjoHuntleigh AB Corporation Information
6.9.2 ArjoHuntleigh AB Description and Business Overview
6.9.3 ArjoHuntleigh AB Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ArjoHuntleigh AB Venous Thromboembolism Therapy Product Portfolio
6.9.5 ArjoHuntleigh AB Recent Developments/Updates
6.10 Argon Medical Devices
6.10.1 Argon Medical Devices Corporation Information
6.10.2 Argon Medical Devices Description and Business Overview
6.10.3 Argon Medical Devices Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Argon Medical Devices Venous Thromboembolism Therapy Product Portfolio
6.10.5 Argon Medical Devices Recent Developments/Updates
6.11 DaeSung Maref
6.11.1 DaeSung Maref Corporation Information
6.11.2 DaeSung Maref Venous Thromboembolism Therapy Description and Business Overview
6.11.3 DaeSung Maref Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.11.4 DaeSung Maref Venous Thromboembolism Therapy Product Portfolio
6.11.5 DaeSung Maref Recent Developments/Updates
6.12 ALN Implants Chirurgicaux
6.12.1 ALN Implants Chirurgicaux Corporation Information
6.12.2 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Description and Business Overview
6.12.3 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Portfolio
6.12.5 ALN Implants Chirurgicaux Recent Developments/Updates
6.13 Lifetech Scientific
6.13.1 Lifetech Scientific Corporation Information
6.13.2 Lifetech Scientific Venous Thromboembolism Therapy Description and Business Overview
6.13.3 Lifetech Scientific Venous Thromboembolism Therapy Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lifetech Scientific Venous Thromboembolism Therapy Product Portfolio
6.13.5 Lifetech Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venous Thromboembolism Therapy Industry Chain Analysis
7.2 Venous Thromboembolism Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venous Thromboembolism Therapy Production Mode & Process
7.4 Venous Thromboembolism Therapy Sales and Marketing
7.4.1 Venous Thromboembolism Therapy Sales Channels
7.4.2 Venous Thromboembolism Therapy Distributors
7.5 Venous Thromboembolism Therapy Customers
8 Venous Thromboembolism Therapy Market Dynamics
8.1 Venous Thromboembolism Therapy Industry Trends
8.2 Venous Thromboembolism Therapy Market Drivers
8.3 Venous Thromboembolism Therapy Market Challenges
8.4 Venous Thromboembolism Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Venous Thromboembolism Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Venous Thromboembolism Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Venous Thromboembolism Therapy Market Competitive Situation by Manufacturers in 2023
Table 4. Global Venous Thromboembolism Therapy Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Venous Thromboembolism Therapy Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Venous Thromboembolism Therapy Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Venous Thromboembolism Therapy Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Venous Thromboembolism Therapy Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Venous Thromboembolism Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Venous Thromboembolism Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Venous Thromboembolism Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Venous Thromboembolism Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Venous Thromboembolism Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapy as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Venous Thromboembolism Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Venous Thromboembolism Therapy Sales by Region (2019-2024) & (K Units)
Table 18. Global Venous Thromboembolism Therapy Sales Market Share by Region (2019-2024)
Table 19. Global Venous Thromboembolism Therapy Sales by Region (2025-2030) & (K Units)
Table 20. Global Venous Thromboembolism Therapy Sales Market Share by Region (2025-2030)
Table 21. Global Venous Thromboembolism Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Venous Thromboembolism Therapy Revenue Market Share by Region (2019-2024)
Table 23. Global Venous Thromboembolism Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Venous Thromboembolism Therapy Revenue Market Share by Region (2025-2030)
Table 25. North America Venous Thromboembolism Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Venous Thromboembolism Therapy Sales by Country (2019-2024) & (K Units)
Table 27. North America Venous Thromboembolism Therapy Sales by Country (2025-2030) & (K Units)
Table 28. North America Venous Thromboembolism Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Venous Thromboembolism Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Venous Thromboembolism Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Venous Thromboembolism Therapy Sales by Country (2019-2024) & (K Units)
Table 32. Europe Venous Thromboembolism Therapy Sales by Country (2025-2030) & (K Units)
Table 33. Europe Venous Thromboembolism Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Venous Thromboembolism Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Venous Thromboembolism Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Venous Thromboembolism Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Venous Thromboembolism Therapy Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Venous Thromboembolism Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Venous Thromboembolism Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Venous Thromboembolism Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Venous Thromboembolism Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Venous Thromboembolism Therapy Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Venous Thromboembolism Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Venous Thromboembolism Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Venous Thromboembolism Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Venous Thromboembolism Therapy Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Venous Thromboembolism Therapy Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Venous Thromboembolism Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Venous Thromboembolism Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Venous Thromboembolism Therapy Sales (K Units) by Type (2019-2024)
Table 51. Global Venous Thromboembolism Therapy Sales (K Units) by Type (2025-2030)
Table 52. Global Venous Thromboembolism Therapy Sales Market Share by Type (2019-2024)
Table 53. Global Venous Thromboembolism Therapy Sales Market Share by Type (2025-2030)
Table 54. Global Venous Thromboembolism Therapy Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Venous Thromboembolism Therapy Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Venous Thromboembolism Therapy Revenue Market Share by Type (2019-2024)
Table 57. Global Venous Thromboembolism Therapy Revenue Market Share by Type (2025-2030)
Table 58. Global Venous Thromboembolism Therapy Price (US$/Unit) by Type (2019-2024)
Table 59. Global Venous Thromboembolism Therapy Price (US$/Unit) by Type (2025-2030)
Table 60. Global Venous Thromboembolism Therapy Sales (K Units) by Application (2019-2024)
Table 61. Global Venous Thromboembolism Therapy Sales (K Units) by Application (2025-2030)
Table 62. Global Venous Thromboembolism Therapy Sales Market Share by Application (2019-2024)
Table 63. Global Venous Thromboembolism Therapy Sales Market Share by Application (2025-2030)
Table 64. Global Venous Thromboembolism Therapy Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Venous Thromboembolism Therapy Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Venous Thromboembolism Therapy Revenue Market Share by Application (2019-2024)
Table 67. Global Venous Thromboembolism Therapy Revenue Market Share by Application (2025-2030)
Table 68. Global Venous Thromboembolism Therapy Price (US$/Unit) by Application (2019-2024)
Table 69. Global Venous Thromboembolism Therapy Price (US$/Unit) by Application (2025-2030)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Medtronic Venous Thromboembolism Therapy Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Boston Scientific Corporation Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Boston Scientific Venous Thromboembolism Therapy Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Stryker Corporation Information
Table 81. Stryker Description and Business Overview
Table 82. Stryker Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Stryker Venous Thromboembolism Therapy Product
Table 84. Stryker Recent Developments/Updates
Table 85. AngioDynamics Corporation Information
Table 86. AngioDynamics Description and Business Overview
Table 87. AngioDynamics Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AngioDynamics Venous Thromboembolism Therapy Product
Table 89. AngioDynamics Recent Developments/Updates
Table 90. Cook Medical Corporation Information
Table 91. Cook Medical Description and Business Overview
Table 92. Cook Medical Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cook Medical Venous Thromboembolism Therapy Product
Table 94. Cook Medical Recent Developments/Updates
Table 95. Cardinal Health Corporation Information
Table 96. Cardinal Health Description and Business Overview
Table 97. Cardinal Health Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cardinal Health Venous Thromboembolism Therapy Product
Table 99. Cardinal Health Recent Developments/Updates
Table 100. DJO Global Corporation Information
Table 101. DJO Global Description and Business Overview
Table 102. DJO Global Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. DJO Global Venous Thromboembolism Therapy Product
Table 104. DJO Global Recent Developments/Updates
Table 105. Philips Holding Corporation Information
Table 106. Philips Holding Description and Business Overview
Table 107. Philips Holding Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Philips Holding Venous Thromboembolism Therapy Product
Table 109. Philips Holding Recent Developments/Updates
Table 110. ArjoHuntleigh AB Corporation Information
Table 111. ArjoHuntleigh AB Description and Business Overview
Table 112. ArjoHuntleigh AB Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. ArjoHuntleigh AB Venous Thromboembolism Therapy Product
Table 114. ArjoHuntleigh AB Recent Developments/Updates
Table 115. Argon Medical Devices Corporation Information
Table 116. Argon Medical Devices Description and Business Overview
Table 117. Argon Medical Devices Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Argon Medical Devices Venous Thromboembolism Therapy Product
Table 119. Argon Medical Devices Recent Developments/Updates
Table 120. DaeSung Maref Corporation Information
Table 121. DaeSung Maref Description and Business Overview
Table 122. DaeSung Maref Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. DaeSung Maref Venous Thromboembolism Therapy Product
Table 124. DaeSung Maref Recent Developments/Updates
Table 125. ALN Implants Chirurgicaux Corporation Information
Table 126. ALN Implants Chirurgicaux Description and Business Overview
Table 127. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product
Table 129. ALN Implants Chirurgicaux Recent Developments/Updates
Table 130. Lifetech Scientific Corporation Information
Table 131. Lifetech Scientific Description and Business Overview
Table 132. Lifetech Scientific Venous Thromboembolism Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Lifetech Scientific Venous Thromboembolism Therapy Product
Table 134. Lifetech Scientific Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Venous Thromboembolism Therapy Distributors List
Table 138. Venous Thromboembolism Therapy Customers List
Table 139. Venous Thromboembolism Therapy Market Trends
Table 140. Venous Thromboembolism Therapy Market Drivers
Table 141. Venous Thromboembolism Therapy Market Challenges
Table 142. Venous Thromboembolism Therapy Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Venous Thromboembolism Therapy
Figure 2. Global Venous Thromboembolism Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Venous Thromboembolism Therapy Market Share by Type in 2023 & 2030
Figure 4. Non-Segmented Pneumatic Compression Pumps Product Picture
Figure 5. Segmented Pneumatic Compression Pumps without Gradient Product Picture
Figure 6. Global Venous Thromboembolism Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Venous Thromboembolism Therapy Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Venous Thromboembolism Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Venous Thromboembolism Therapy Market Size (2019-2030) & (US$ Million)
Figure 13. Global Venous Thromboembolism Therapy Sales (2019-2030) & (K Units)
Figure 14. Global Venous Thromboembolism Therapy Average Price (US$/Unit) & (2019-2030)
Figure 15. Venous Thromboembolism Therapy Report Years Considered
Figure 16. Venous Thromboembolism Therapy Sales Share by Manufacturers in 2023
Figure 17. Global Venous Thromboembolism Therapy Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Venous Thromboembolism Therapy Players: Market Share by Revenue in 2023
Figure 19. Venous Thromboembolism Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Venous Thromboembolism Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Venous Thromboembolism Therapy Sales Market Share by Country (2019-2030)
Figure 22. North America Venous Thromboembolism Therapy Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Venous Thromboembolism Therapy Sales Market Share by Country (2019-2030)
Figure 26. Europe Venous Thromboembolism Therapy Revenue Market Share by Country (2019-2030)
Figure 27. Germany Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Venous Thromboembolism Therapy Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Venous Thromboembolism Therapy Revenue Market Share by Region (2019-2030)
Figure 34. China Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Venous Thromboembolism Therapy Sales Market Share by Country (2019-2030)
Figure 45. Latin America Venous Thromboembolism Therapy Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Venous Thromboembolism Therapy Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Venous Thromboembolism Therapy Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Venous Thromboembolism Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Venous Thromboembolism Therapy by Type (2019-2030)
Figure 55. Global Revenue Market Share of Venous Thromboembolism Therapy by Type (2019-2030)
Figure 56. Global Venous Thromboembolism Therapy Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Venous Thromboembolism Therapy by Application (2019-2030)
Figure 58. Global Revenue Market Share of Venous Thromboembolism Therapy by Application (2019-2030)
Figure 59. Global Venous Thromboembolism Therapy Price (US$/Unit) by Application (2019-2030)
Figure 60. Venous Thromboembolism Therapy Value Chain
Figure 61. Venous Thromboembolism Therapy Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock